Brief: Graphite Bio Reports Q1 2022 Financial Results

LENZ Therapeutics

12/05/2022 22:18

May 12 (Reuters) - Graphite Bio Inc  GRPH.O :
    * GRAPHITE BIO REPORTS RECENT BUSINESS PROGRESS AND FIRST
QUARTER
2022 FINANCIAL RESULTS
    * GRAPHITE BIO - $352.1 MILLION IN CASH, CASH EQUIVALENTS
AND
INVESTMENTS IN MARKETABLE SECURITIES AS OF MARCH 31, 2022; CASH
RUNWAY INTO Q4 OF 2024
    * QTRLY NET LOSS PER COMMON SHARE - BASIC AND DILUTED $0.48
    * Q1 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwnjZZqa 
Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))